Concepts (143)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cocaine | 6 | 2018 | 232 | 2.060 |
Why?
|
| Astrocytes | 5 | 2019 | 255 | 1.520 |
Why?
|
| Apoptosis | 6 | 2019 | 1398 | 0.840 |
Why?
|
| Gallic Acid | 2 | 2012 | 15 | 0.820 |
Why?
|
| Receptors, Opioid, mu | 2 | 2012 | 55 | 0.810 |
Why?
|
| Morphine | 2 | 2012 | 85 | 0.800 |
Why?
|
| Cell Survival | 13 | 2019 | 864 | 0.730 |
Why?
|
| Reactive Oxygen Species | 4 | 2019 | 461 | 0.710 |
Why?
|
| Plant Extracts | 2 | 2014 | 286 | 0.710 |
Why?
|
| Acetylcysteine | 3 | 2015 | 62 | 0.690 |
Why?
|
| Glutathione | 6 | 2019 | 179 | 0.660 |
Why?
|
| Neurites | 2 | 2018 | 39 | 0.630 |
Why?
|
| Rats | 13 | 2019 | 3483 | 0.610 |
Why?
|
| Membrane Potential, Mitochondrial | 3 | 2018 | 84 | 0.590 |
Why?
|
| Central Nervous System Stimulants | 1 | 2019 | 174 | 0.590 |
Why?
|
| Methamphetamine | 1 | 2019 | 159 | 0.590 |
Why?
|
| Gene Expression Regulation | 3 | 2015 | 1015 | 0.590 |
Why?
|
| Free Radical Scavengers | 2 | 2014 | 66 | 0.510 |
Why?
|
| Prostatic Neoplasms | 3 | 2014 | 935 | 0.490 |
Why?
|
| Seeds | 1 | 2014 | 35 | 0.490 |
Why?
|
| Antioxidants | 2 | 2015 | 416 | 0.480 |
Why?
|
| Artemia | 2 | 2014 | 16 | 0.470 |
Why?
|
| Cell Cycle | 3 | 2016 | 326 | 0.410 |
Why?
|
| Neurons | 2 | 2018 | 1175 | 0.410 |
Why?
|
| Narcotics | 1 | 2011 | 32 | 0.400 |
Why?
|
| Analgesics, Opioid | 1 | 2012 | 197 | 0.370 |
Why?
|
| Animals | 15 | 2019 | 15081 | 0.370 |
Why?
|
| Prostate | 1 | 2011 | 154 | 0.360 |
Why?
|
| Pyrrolidines | 1 | 2009 | 29 | 0.340 |
Why?
|
| Piperidines | 1 | 2009 | 77 | 0.330 |
Why?
|
| Stilbenes | 1 | 2009 | 44 | 0.330 |
Why?
|
| Cell Line | 4 | 2019 | 1354 | 0.330 |
Why?
|
| Adenocarcinoma | 1 | 2009 | 251 | 0.290 |
Why?
|
| Antineoplastic Agents | 2 | 2016 | 803 | 0.290 |
Why?
|
| Nitric Oxide | 3 | 2018 | 316 | 0.240 |
Why?
|
| Cell Line, Tumor | 6 | 2016 | 2231 | 0.240 |
Why?
|
| Vacuoles | 2 | 2014 | 25 | 0.210 |
Why?
|
| PC12 Cells | 4 | 2018 | 93 | 0.210 |
Why?
|
| RNA, Messenger | 3 | 2015 | 1207 | 0.170 |
Why?
|
| Nerve Growth Factor | 2 | 2018 | 30 | 0.170 |
Why?
|
| Dose-Response Relationship, Drug | 5 | 2015 | 1039 | 0.170 |
Why?
|
| Lipid Peroxidation | 1 | 2019 | 140 | 0.160 |
Why?
|
| Breast Neoplasms | 1 | 2009 | 1502 | 0.160 |
Why?
|
| Lactic Acid | 1 | 2018 | 95 | 0.150 |
Why?
|
| Cystatins | 2 | 2007 | 19 | 0.140 |
Why?
|
| Tetrahydroisoquinolines | 1 | 2016 | 21 | 0.140 |
Why?
|
| Lysosomes | 2 | 2007 | 91 | 0.140 |
Why?
|
| Microtubules | 1 | 2016 | 120 | 0.130 |
Why?
|
| Benzoquinones | 1 | 2015 | 36 | 0.130 |
Why?
|
| Methylation | 1 | 2015 | 113 | 0.120 |
Why?
|
| Cell Shape | 1 | 2014 | 35 | 0.120 |
Why?
|
| Time Factors | 1 | 2019 | 1742 | 0.120 |
Why?
|
| Cytoskeleton | 1 | 2015 | 110 | 0.120 |
Why?
|
| Cytochromes c | 2 | 2012 | 53 | 0.120 |
Why?
|
| Selective Estrogen Receptor Modulators | 1 | 2014 | 32 | 0.120 |
Why?
|
| Dogs | 1 | 2014 | 149 | 0.120 |
Why?
|
| Caspases | 2 | 2012 | 147 | 0.120 |
Why?
|
| Microglia | 1 | 2015 | 166 | 0.110 |
Why?
|
| Histones | 1 | 2015 | 190 | 0.110 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2015 | 149 | 0.110 |
Why?
|
| Oxidants | 1 | 2013 | 45 | 0.110 |
Why?
|
| Proteome | 1 | 2014 | 144 | 0.110 |
Why?
|
| Naloxone | 1 | 2012 | 52 | 0.110 |
Why?
|
| Cell Membrane | 1 | 2015 | 381 | 0.110 |
Why?
|
| Narcotic Antagonists | 1 | 2012 | 57 | 0.110 |
Why?
|
| CHO Cells | 1 | 2012 | 124 | 0.110 |
Why?
|
| Cell Respiration | 1 | 2012 | 35 | 0.110 |
Why?
|
| Estradiol | 1 | 2014 | 262 | 0.100 |
Why?
|
| Cricetinae | 1 | 2012 | 238 | 0.100 |
Why?
|
| Dihydrotestosterone | 1 | 2011 | 29 | 0.100 |
Why?
|
| Proteomics | 1 | 2014 | 325 | 0.100 |
Why?
|
| Hypothalamus | 1 | 2011 | 129 | 0.090 |
Why?
|
| Mitochondria | 2 | 2012 | 487 | 0.090 |
Why?
|
| Oxidation-Reduction | 1 | 2012 | 431 | 0.090 |
Why?
|
| Cathepsin D | 2 | 2007 | 17 | 0.090 |
Why?
|
| Cathepsin B | 2 | 2007 | 26 | 0.090 |
Why?
|
| Humans | 7 | 2016 | 37093 | 0.090 |
Why?
|
| Male | 4 | 2014 | 20025 | 0.090 |
Why?
|
| Astrocytoma | 1 | 2009 | 14 | 0.090 |
Why?
|
| G2 Phase | 1 | 2009 | 29 | 0.090 |
Why?
|
| Caspase 3 | 2 | 2007 | 207 | 0.090 |
Why?
|
| Biological Assay | 1 | 2009 | 59 | 0.080 |
Why?
|
| Larva | 1 | 2009 | 124 | 0.080 |
Why?
|
| Cell Division | 1 | 2009 | 307 | 0.080 |
Why?
|
| Neuroglia | 1 | 2009 | 124 | 0.080 |
Why?
|
| Flow Cytometry | 1 | 2009 | 399 | 0.080 |
Why?
|
| Cells, Cultured | 1 | 2011 | 1518 | 0.080 |
Why?
|
| Dopamine Agents | 1 | 2007 | 25 | 0.070 |
Why?
|
| 1-Methyl-4-phenylpyridinium | 1 | 2007 | 30 | 0.070 |
Why?
|
| Glycolysis | 1 | 2007 | 68 | 0.070 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2011 | 1618 | 0.070 |
Why?
|
| Glioma | 1 | 2007 | 79 | 0.070 |
Why?
|
| Liver | 1 | 2009 | 479 | 0.070 |
Why?
|
| Phencyclidine | 1 | 2006 | 19 | 0.070 |
Why?
|
| Hydrogen Peroxide | 1 | 2007 | 190 | 0.070 |
Why?
|
| Sympatholytics | 1 | 2006 | 14 | 0.070 |
Why?
|
| Oxidopamine | 1 | 2006 | 20 | 0.070 |
Why?
|
| Peptide Hydrolases | 1 | 2006 | 40 | 0.070 |
Why?
|
| Excitatory Amino Acid Antagonists | 1 | 2006 | 99 | 0.070 |
Why?
|
| Brain Neoplasms | 1 | 2007 | 111 | 0.070 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2006 | 137 | 0.060 |
Why?
|
| Cell Proliferation | 3 | 2016 | 1198 | 0.060 |
Why?
|
| Cell Differentiation | 1 | 2006 | 587 | 0.050 |
Why?
|
| Cystatin C | 2 | 2007 | 24 | 0.040 |
Why?
|
| L-Lactate Dehydrogenase | 2 | 2007 | 62 | 0.030 |
Why?
|
| In Situ Nick-End Labeling | 2 | 2007 | 133 | 0.030 |
Why?
|
| Poly(ADP-ribose) Polymerases | 2 | 2007 | 78 | 0.030 |
Why?
|
| Tubulin | 1 | 2016 | 88 | 0.030 |
Why?
|
| Nitrites | 1 | 2015 | 46 | 0.030 |
Why?
|
| Cell Line, Transformed | 1 | 2015 | 91 | 0.030 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2015 | 115 | 0.030 |
Why?
|
| Lysine | 1 | 2015 | 113 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2015 | 448 | 0.030 |
Why?
|
| Lipopolysaccharides | 1 | 2015 | 220 | 0.030 |
Why?
|
| Blotting, Western | 2 | 2006 | 859 | 0.030 |
Why?
|
| Enzyme Inhibitors | 1 | 2015 | 433 | 0.030 |
Why?
|
| Cytokines | 1 | 2015 | 602 | 0.020 |
Why?
|
| Oxidative Stress | 2 | 2007 | 938 | 0.020 |
Why?
|
| Female | 1 | 2009 | 20969 | 0.020 |
Why?
|
| Fluorescein | 1 | 2007 | 16 | 0.020 |
Why?
|
| Anaerobiosis | 1 | 2007 | 15 | 0.020 |
Why?
|
| Luminescence | 1 | 2007 | 24 | 0.020 |
Why?
|
| Cysteine Proteinase Inhibitors | 1 | 2007 | 22 | 0.020 |
Why?
|
| Cytoplasm | 1 | 2007 | 143 | 0.020 |
Why?
|
| Membrane Potentials | 1 | 2007 | 223 | 0.020 |
Why?
|
| Biogenic Amines | 1 | 2006 | 11 | 0.020 |
Why?
|
| Tritium | 1 | 2006 | 51 | 0.020 |
Why?
|
| Dizocilpine Maleate | 1 | 2006 | 48 | 0.020 |
Why?
|
| Stimulation, Chemical | 1 | 2006 | 22 | 0.020 |
Why?
|
| Fluorescent Dyes | 1 | 2007 | 181 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 2007 | 252 | 0.020 |
Why?
|
| Adenosine Triphosphate | 1 | 2007 | 196 | 0.020 |
Why?
|
| N-Methylaspartate | 1 | 2006 | 57 | 0.020 |
Why?
|
| Drug Interactions | 1 | 2006 | 141 | 0.020 |
Why?
|
| Glucose | 1 | 2007 | 230 | 0.020 |
Why?
|
| Glutamic Acid | 1 | 2006 | 128 | 0.020 |
Why?
|
| Cell Death | 1 | 2006 | 267 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2006 | 550 | 0.020 |
Why?
|
| Mice | 1 | 2015 | 5913 | 0.010 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2006 | 421 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2006 | 893 | 0.010 |
Why?
|
| Protein Binding | 1 | 2006 | 972 | 0.010 |
Why?
|
| DNA | 1 | 2006 | 574 | 0.010 |
Why?
|